US Patent

US11938136 — Compositions for treating spinal muscular atrophy

Formulation · Assigned to Hoffmann La Roche Inc · Expires 2036-11-08 · 10y remaining

Vulnerability score 55/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects pharmaceutical compositions containing a compound of formula (I) and its pharmaceutically acceptable salts, used as medicaments.

USPTO Abstract

The present invention provides pharmaceutical compositions comprising a compound of formula (I) wherein A, R 1 , R 2 and R 3 are as described herein, as well as pharmaceutically acceptable salts thereof. Further the present invention is concerned with the manufacture of the pharmaceutical compositions comprising a compound of formula (I) and their use as medicaments.

Drugs covered by this patent

Patent Metadata

Patent number
US11938136
Jurisdiction
US
Classification
Formulation
Expires
2036-11-08
Drug substance claim
No
Drug product claim
Yes
Assignee
Hoffmann La Roche Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.